The number of global cases of COVID-19 rose above 4.31 million on Wednesday, as Russia counted another 10,000 infections and Brazil and Mexico suffered their deadliest day since the start of the pandemic.

BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it has priced its previously announced registered offerings of $1.5 billion of common stock, par value $1.00 per share, at a public offering price of $240.00 per share, and $1.5 billion of depositary shares, each representing a 1/20th interest in a share of 6.00% Mandatory Convertible Preferred Stock, Series B, par value $1.00 per share, at a public offering price of $50.00 per share. Pursuant to the offerings, BD has granted the underwriters an option to purchase from BD up to an additional $225 million of common stock and up to an additional $225 million of depositary shares, in each case at the public offering price per share.

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are…

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.79 per common share, payable on June 30, 2020 to holders of record on June 9, 2020. The indicated annual dividend rate is $3.16 per share.

Health-care stocks that were popular in ESG funds tended to score better on ESG issues than other stocks in the sector in conventional funds, according to a study.

Despite legal troubles with investors, Becton Dickinson has shown remarkable agility for its size with its COVID-19 testing program.

Former US vice president's firm releases 1st-quarter portfolio Continue reading...

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each […]

Until mid-February this year, markets were making new all-time highs. Then suddenly, they were hit hard by a pandemic and resulting economic shutdowns that no one could have predicted.From time to time, especially after a big market correction, we like to stu…

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the m…

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filings submitted by hedge funds and prominent investors. These f…

William Von Mueffling's 13F portfolio value decreased this quarter from $10.75B to $9.04B. They added Applied Materials, Microsoft, and W R Grace & Co during the quarter. The portfolio continues to be very concentrated with the top five positi…

Moody's Investors Service ("Moody's") assigned a Ba1 rating to the new senior unsecured note issuance by Becton, Dickinson and Company ("BD"). There are no changes to BD's existing ratings including its Ba1 Corporate Family Rating, SGL-1 Speculative Grade Liquidity rating and the outlook remains positive. The transaction is credit positive as it is leverage-neutral and will extend BD's debt maturity profile.

The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in NYSE: BDX shares. Investors, who purchased shares of Becton, Dickinson and Company (BDX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On February 27, 2020, a lawsuit was filed against Becton, Dickinson and Company over alleged Securities Laws Violations.

With COVID-19 uncertainties everywhere, many companies are suspending share buybacks and some companies are cutting or suspending their dividends.Dividend cuts are mostly concentrated within oil/gas, aviation, tourism, and hospitality.The Dividend Sustainabil…

The "Data Centre China 2020 to 2025: Innovation & Change - Chinese Data Centre Expansion" report has been added to ResearchAndMarkets.com's offering.

Family-influenced, niche leadership, predictable sales and promising growth prospects Continue reading...

Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down…

Becton Dickinson (BDX) delivered earnings and revenue surprises of 11.84% and 3.43%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Becton Dickinson's (BDX) second-quarter results reflect solid performance by the core Life Sciences and Interventional segments.

Q1 was one of the most volatile quarters in market history, as stocks hit new all-time highs and then dropped by thirty percent.The DGI For The DIY portfolio also took a valuation hit, and saw two dividend cuts from stocks owned.Dividend income rose by nearly…

Q2 2020 Becton Dickinson and Co Earnings Call

BDX earnings call for the period ending March 31, 2020.

Select healthcare companies are seeing a strong bid from the race for potential treatments, a vaccine and testing for COVID-19.We believe their success in these efforts will have more impact in reopening the economy than as long-term stock catalysts.Biopharma…

A treatment is needed for ARDS.Remdesivir was touted by STAT.Antiviral efficacy and side effects are under scrutiny.CytoDyn is closest to a trial readout.

BDX earnings call for the period ending March 31, 2020.

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings…

The U.S. Treasury is gearing up to auction a $3 trillion in debt to finance the growing federal budget deficit. Charles Schwab Chief Fixed Income Strategist Kathy Jones joins Yahoo Finance’s Seana Smith to discuss.

Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Becton, Dickinson and Company and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down…

LOS ANGELES--(BUSINESS WIRE)---- $BDX #BDX--MONDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Becton, Dickinson and Company.

Stock market headwinds emerging at resistance.Stock picking is key given uncertainty.Here are the top stocks to buy now.

Medical Product companies have partially mitigated the impact of the pandemic with the massive adoption of COVID-19 related healthcare-support products and services.

Medical technology company Becton Dickinson and Co said on Thursday it was preparing to ramp up manufacturing operations to handle demand for COVID-19 testing kits in the event of a second wave of infections in the fall. The respiratory illness caused by the novel coronavirus has infected over 1.1 million people and claimed over 70,000 lives in the United States, and experts have warned a second wave of the outbreak could be much worse as it would likely arrive with the start of the influenza season. Among the many tests Becton Dickinson has launched over the past month is a test kit that can give results in two to three hours as well as an antibody test that can confirm current or past exposure to COVID-19 in as little as 15 minutes.

BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it has commenced registered offerings of $1.5 billion of common stock, par value $1.00 per share, and $1.5 billion of depositary shares, each representing a 1/20th interest in its mandatory convertible preferred stock, par value $1.00 per share, Series B. Pursuant to the offerings, BD intends to grant the underwriters an option to purchase from BD up to an additional $225 million of common stock and up to an additional $225 million of depositary shares.

SIG SAUER Electro-Optics have announced the launch of a new line of scopes using their Ballistic Data Xchange (BDX) technology. The new SIERRA6BDX riflescopes will be available in 2-12x40mm, 3-18x44mm and 5-30x56mm, with MSRP ranging from  $1,169.99 to $1,689…

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the m…

Becton Dickinson & Co. disclosed Wednesday it was offering the sale of $1.5 billion in 10-year and 30-year notes, as the medical technology company looks to repay $1 billion in debt due this year. The offerings include $750 million in 2.823% notes due 2030 and $750 million in 3.794% notes due 2050. That compares with the yield on the 10-year Treasury note of 0.678% and the yield on the 30-year Treasury bond of 1.381%. The company said it expects to use the proceeds plus cash on hand to repay the $1 billion in 2.404% notes due 2020, and to fund a partial redemption of its 3.250% notes, also due this year. Becton Dickinson's stock, which was still inactive in premarket trading, has gained 3.0% over the past three months while the S&P 500 has lost 14.9%.

"Everyone has a plan until they get punched in the mouth." Fearsome former heavyweight champ Mike Tyson wasn't talking about investors when he dispensed that particular piece of wisdom. But with the walloping portfolios have taken in recent months, he might a…

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the Jefferies Virtual Healthcare Conference on Thursday, June 4, 2020, at 11:00 a.m. ET.